Connect with us

Hi, what are you looking for?

Jewish Business News


IMI privatization moving forward

Market sources estimate that Israel Military Industries is worth $657 million.

Israel Military Industries (IMI)


The privatization of Israel Military Industries Ltd. (IMI) is moving forward as planned said Government Companies Authority head Ori Yogev after a visit to the company’s plants in Ramat Hasharon. At the start of the year the Government Companies Authority published a call to private investors to to compete for acquisition of the defense company, which is fully owned by the Israeli government. When the privatization process is completed, the company will move its plant to the Negev, thus freeing up large tracts of valuable land in Ramat Hasharon.

Market sources estimate that the government could fetch $657 million for IMI. One highly classified unit of the company will be separated from IMI and called Tomer Systems in order to protect state interests.

Yogev was shown around the company by Chairman General (res.) Udi Adam and CEO Avi Felder. They discussed the company’s products portfolio, new organizational structure and progress in the voluntary retirement of hundreds of employees as agreed with the Histadrut, Ministry of Defense and Ministry of Finance, and approved by the cabinet. By the end of the year 700 employees would have taken early retirement, and they will be joined by hundreds more next year.

Adam said, “The aim of the company is to maximize value and increase its order backlog and develop advanced weapons systems and technologies.”

Felder said that the order backlog stood at $2.1 billion.

Published by Globes [online], Israel business news –

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.



You May Also Like

World News

In the 15th Nov 2015 edition of Israel’s good news, the highlights include:   ·         A new Israeli treatment brings hope to relapsed leukemia...


The contract signed between the Israeli government and Pfizer shows clearly and unequivocally that this is a clinical study on humans - The agreement...


Now Platika joins and elite club of $10 billion plus Israeli firms.


After two decades without a rating system in Israel, at the end of 2012 an international tender for hotel rating was published.  Invited to place bids...